Cargando…

The development of end stage renal disease in two patients with PMM2‐CDG

We report two patients with PMM2‐CDG who developed end stage renal disease (ESRD). Renal abnormalities of clinical significance have only been reported in about 6% of patients with PMM2‐CDG and have rarely been reported as the cause of death. Given the recurrent episodes of acute kidney injury assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwary, Henna, Hecht, Leah E., Brucker, William J., Berry, Gerard T., Rodig, Nancy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898725/
https://www.ncbi.nlm.nih.gov/pubmed/35281664
http://dx.doi.org/10.1002/jmd2.12269
_version_ 1784663721621061632
author Tiwary, Henna
Hecht, Leah E.
Brucker, William J.
Berry, Gerard T.
Rodig, Nancy M.
author_facet Tiwary, Henna
Hecht, Leah E.
Brucker, William J.
Berry, Gerard T.
Rodig, Nancy M.
author_sort Tiwary, Henna
collection PubMed
description We report two patients with PMM2‐CDG who developed end stage renal disease (ESRD). Renal abnormalities of clinical significance have only been reported in about 6% of patients with PMM2‐CDG and have rarely been reported as the cause of death. Given the recurrent episodes of acute kidney injury associated with hospital admissions and the accelerated development of ESRD thereafter in our two patients, we recommend proactively involving Nephrology early in the care of these patients.
format Online
Article
Text
id pubmed-8898725
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-88987252022-03-11 The development of end stage renal disease in two patients with PMM2‐CDG Tiwary, Henna Hecht, Leah E. Brucker, William J. Berry, Gerard T. Rodig, Nancy M. JIMD Rep Case Reports We report two patients with PMM2‐CDG who developed end stage renal disease (ESRD). Renal abnormalities of clinical significance have only been reported in about 6% of patients with PMM2‐CDG and have rarely been reported as the cause of death. Given the recurrent episodes of acute kidney injury associated with hospital admissions and the accelerated development of ESRD thereafter in our two patients, we recommend proactively involving Nephrology early in the care of these patients. John Wiley & Sons, Inc. 2022-01-10 /pmc/articles/PMC8898725/ /pubmed/35281664 http://dx.doi.org/10.1002/jmd2.12269 Text en © 2022 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Tiwary, Henna
Hecht, Leah E.
Brucker, William J.
Berry, Gerard T.
Rodig, Nancy M.
The development of end stage renal disease in two patients with PMM2‐CDG
title The development of end stage renal disease in two patients with PMM2‐CDG
title_full The development of end stage renal disease in two patients with PMM2‐CDG
title_fullStr The development of end stage renal disease in two patients with PMM2‐CDG
title_full_unstemmed The development of end stage renal disease in two patients with PMM2‐CDG
title_short The development of end stage renal disease in two patients with PMM2‐CDG
title_sort development of end stage renal disease in two patients with pmm2‐cdg
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898725/
https://www.ncbi.nlm.nih.gov/pubmed/35281664
http://dx.doi.org/10.1002/jmd2.12269
work_keys_str_mv AT tiwaryhenna thedevelopmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT hechtleahe thedevelopmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT bruckerwilliamj thedevelopmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT berrygerardt thedevelopmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT rodignancym thedevelopmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT tiwaryhenna developmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT hechtleahe developmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT bruckerwilliamj developmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT berrygerardt developmentofendstagerenaldiseaseintwopatientswithpmm2cdg
AT rodignancym developmentofendstagerenaldiseaseintwopatientswithpmm2cdg